Differential Impact of ApoE ε4 on Cortical Activation During Famous Face Recognition in Cognitively Intact Individuals and Patients With Amnestic Mild Cognitive Impairment

This study explores the neurofunctional correlates of the recognition of famous faces in patients with amnestic mild cognitive impairment (aMCI) and healthy controls depending on the genetic risk factor, Apolipoprotein E (ApoE) ε4. An event-related functional magnetic resonance imaging experiment wa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alzheimer disease and associated disorders 2011-07, Vol.25 (3), p.250-261
Hauptverfasser: FRANK, Gabriele, HENNIG-FAST, Kristina, KLÜNEMANN, Hans H, SCHMITZ, Gerd, GREENLEE, Mark W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 261
container_issue 3
container_start_page 250
container_title Alzheimer disease and associated disorders
container_volume 25
creator FRANK, Gabriele
HENNIG-FAST, Kristina
KLÜNEMANN, Hans H
SCHMITZ, Gerd
GREENLEE, Mark W
description This study explores the neurofunctional correlates of the recognition of famous faces in patients with amnestic mild cognitive impairment (aMCI) and healthy controls depending on the genetic risk factor, Apolipoprotein E (ApoE) ε4. An event-related functional magnetic resonance imaging experiment was conducted while participants discriminated between famous and nonfamous faces. We compared the results of 32 healthy controls [17 ApoE ε4 carriers (E4+); 15 noncarriers (E4-)] with those of 30 patients with aMCI (16 E4+; 14 E4-). Despite comparable task performance, patients with aMCI, E4+ showed significantly less activation in a large cortical network including the left parahippocampal gyrus than patients with aMCI E4-. Furthermore, in the aMCI group, we found significantly reduced activation in the left parahippocampal gyrus and posterior cingulate cortex compared with the control group. Our results show that critical regions of the brain show functional decline associated with major risk factors, such as ApoE ε4 allele and neuropsychological signs of aMCI for the development of Alzheimer disease. Importantly, the ApoE genotype seems to influence cortical activation in patients with aMCI and to a lesser degree in healthy controls as well, who are without any cognitive symptoms.
doi_str_mv 10.1097/WAD.0b013e3182061636
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_885296584</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>885296584</sourcerecordid><originalsourceid>FETCH-LOGICAL-c251t-650ce86486449f5d16887525cc93aacb8aca006e051d1cb1a92790f734e98a6b3</originalsourceid><addsrcrecordid>eNpdUctq3DAUFSUlmTz-oBRtSlZOr6yHpaWZyWMgJaE0ZGlkWU5VbHkq2QP5p2zzG_mmaCbTBgKCi-49jysdhL4QOCOgiu_35eIMaiDUUiJzEERQ8QnNCGciY4SLPTQDqWgGlJEDdBjjHwAoKId9dJATovKc8hl6Wri2tcH60ekOL_uVNiMeWlyuhnP88szw4PF8CKMzaVya0a316FJvMQXnH_CF7ocppmIs_mnN8ODdduw2rO1lbbtHvPTjRnfpG7d2zaS7iLVv8G3SSs4R37vxNy57b2Mywj9c17zTt0u50CfgMfrcJq492dUjdHdx_mt-lV3fXC7n5XVmck7GTHAwVgqWDlMtb4iQsuA5N0ZRrU0ttdEAwgInDTE10SovFLQFZVZJLWp6hE7fdFdh-DulpareRWO7TnubnltJyXMluGQJyd6QJgwxBttWq-B6HR4rAtUmpirFVH2MKdG-7gymurfNf9K_XBLg2w6gY_r5NmhvXHzHMQ5cSEFfAUZYngE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>885296584</pqid></control><display><type>article</type><title>Differential Impact of ApoE ε4 on Cortical Activation During Famous Face Recognition in Cognitively Intact Individuals and Patients With Amnestic Mild Cognitive Impairment</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>FRANK, Gabriele ; HENNIG-FAST, Kristina ; KLÜNEMANN, Hans H ; SCHMITZ, Gerd ; GREENLEE, Mark W</creator><creatorcontrib>FRANK, Gabriele ; HENNIG-FAST, Kristina ; KLÜNEMANN, Hans H ; SCHMITZ, Gerd ; GREENLEE, Mark W</creatorcontrib><description>This study explores the neurofunctional correlates of the recognition of famous faces in patients with amnestic mild cognitive impairment (aMCI) and healthy controls depending on the genetic risk factor, Apolipoprotein E (ApoE) ε4. An event-related functional magnetic resonance imaging experiment was conducted while participants discriminated between famous and nonfamous faces. We compared the results of 32 healthy controls [17 ApoE ε4 carriers (E4+); 15 noncarriers (E4-)] with those of 30 patients with aMCI (16 E4+; 14 E4-). Despite comparable task performance, patients with aMCI, E4+ showed significantly less activation in a large cortical network including the left parahippocampal gyrus than patients with aMCI E4-. Furthermore, in the aMCI group, we found significantly reduced activation in the left parahippocampal gyrus and posterior cingulate cortex compared with the control group. Our results show that critical regions of the brain show functional decline associated with major risk factors, such as ApoE ε4 allele and neuropsychological signs of aMCI for the development of Alzheimer disease. Importantly, the ApoE genotype seems to influence cortical activation in patients with aMCI and to a lesser degree in healthy controls as well, who are without any cognitive symptoms.</description><identifier>ISSN: 0893-0341</identifier><identifier>EISSN: 1546-4156</identifier><identifier>DOI: 10.1097/WAD.0b013e3182061636</identifier><identifier>PMID: 21192235</identifier><identifier>CODEN: ADADE2</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Amnesia - genetics ; Apolipoprotein E4 - genetics ; Biological and medical sciences ; Cognitive Dysfunction - diagnosis ; Cognitive Dysfunction - genetics ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Female ; Genetic Predisposition to Disease - genetics ; Genotype ; Humans ; Image Interpretation, Computer-Assisted ; Magnetic Resonance Imaging ; Male ; Medical sciences ; Memory Disorders - genetics ; Middle Aged ; Neurology ; Neuropharmacology ; Neuropsychological Tests ; Pattern Recognition, Visual - physiology ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Recognition (Psychology) - physiology</subject><ispartof>Alzheimer disease and associated disorders, 2011-07, Vol.25 (3), p.250-261</ispartof><rights>2015 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c251t-650ce86486449f5d16887525cc93aacb8aca006e051d1cb1a92790f734e98a6b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24505686$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21192235$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>FRANK, Gabriele</creatorcontrib><creatorcontrib>HENNIG-FAST, Kristina</creatorcontrib><creatorcontrib>KLÜNEMANN, Hans H</creatorcontrib><creatorcontrib>SCHMITZ, Gerd</creatorcontrib><creatorcontrib>GREENLEE, Mark W</creatorcontrib><title>Differential Impact of ApoE ε4 on Cortical Activation During Famous Face Recognition in Cognitively Intact Individuals and Patients With Amnestic Mild Cognitive Impairment</title><title>Alzheimer disease and associated disorders</title><addtitle>Alzheimer Dis Assoc Disord</addtitle><description>This study explores the neurofunctional correlates of the recognition of famous faces in patients with amnestic mild cognitive impairment (aMCI) and healthy controls depending on the genetic risk factor, Apolipoprotein E (ApoE) ε4. An event-related functional magnetic resonance imaging experiment was conducted while participants discriminated between famous and nonfamous faces. We compared the results of 32 healthy controls [17 ApoE ε4 carriers (E4+); 15 noncarriers (E4-)] with those of 30 patients with aMCI (16 E4+; 14 E4-). Despite comparable task performance, patients with aMCI, E4+ showed significantly less activation in a large cortical network including the left parahippocampal gyrus than patients with aMCI E4-. Furthermore, in the aMCI group, we found significantly reduced activation in the left parahippocampal gyrus and posterior cingulate cortex compared with the control group. Our results show that critical regions of the brain show functional decline associated with major risk factors, such as ApoE ε4 allele and neuropsychological signs of aMCI for the development of Alzheimer disease. Importantly, the ApoE genotype seems to influence cortical activation in patients with aMCI and to a lesser degree in healthy controls as well, who are without any cognitive symptoms.</description><subject>Amnesia - genetics</subject><subject>Apolipoprotein E4 - genetics</subject><subject>Biological and medical sciences</subject><subject>Cognitive Dysfunction - diagnosis</subject><subject>Cognitive Dysfunction - genetics</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Female</subject><subject>Genetic Predisposition to Disease - genetics</subject><subject>Genotype</subject><subject>Humans</subject><subject>Image Interpretation, Computer-Assisted</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Memory Disorders - genetics</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Neuropharmacology</subject><subject>Neuropsychological Tests</subject><subject>Pattern Recognition, Visual - physiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Recognition (Psychology) - physiology</subject><issn>0893-0341</issn><issn>1546-4156</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdUctq3DAUFSUlmTz-oBRtSlZOr6yHpaWZyWMgJaE0ZGlkWU5VbHkq2QP5p2zzG_mmaCbTBgKCi-49jysdhL4QOCOgiu_35eIMaiDUUiJzEERQ8QnNCGciY4SLPTQDqWgGlJEDdBjjHwAoKId9dJATovKc8hl6Wri2tcH60ekOL_uVNiMeWlyuhnP88szw4PF8CKMzaVya0a316FJvMQXnH_CF7ocppmIs_mnN8ODdduw2rO1lbbtHvPTjRnfpG7d2zaS7iLVv8G3SSs4R37vxNy57b2Mywj9c17zTt0u50CfgMfrcJq492dUjdHdx_mt-lV3fXC7n5XVmck7GTHAwVgqWDlMtb4iQsuA5N0ZRrU0ttdEAwgInDTE10SovFLQFZVZJLWp6hE7fdFdh-DulpareRWO7TnubnltJyXMluGQJyd6QJgwxBttWq-B6HR4rAtUmpirFVH2MKdG-7gymurfNf9K_XBLg2w6gY_r5NmhvXHzHMQ5cSEFfAUZYngE</recordid><startdate>201107</startdate><enddate>201107</enddate><creator>FRANK, Gabriele</creator><creator>HENNIG-FAST, Kristina</creator><creator>KLÜNEMANN, Hans H</creator><creator>SCHMITZ, Gerd</creator><creator>GREENLEE, Mark W</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201107</creationdate><title>Differential Impact of ApoE ε4 on Cortical Activation During Famous Face Recognition in Cognitively Intact Individuals and Patients With Amnestic Mild Cognitive Impairment</title><author>FRANK, Gabriele ; HENNIG-FAST, Kristina ; KLÜNEMANN, Hans H ; SCHMITZ, Gerd ; GREENLEE, Mark W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c251t-650ce86486449f5d16887525cc93aacb8aca006e051d1cb1a92790f734e98a6b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Amnesia - genetics</topic><topic>Apolipoprotein E4 - genetics</topic><topic>Biological and medical sciences</topic><topic>Cognitive Dysfunction - diagnosis</topic><topic>Cognitive Dysfunction - genetics</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Female</topic><topic>Genetic Predisposition to Disease - genetics</topic><topic>Genotype</topic><topic>Humans</topic><topic>Image Interpretation, Computer-Assisted</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Memory Disorders - genetics</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Neuropharmacology</topic><topic>Neuropsychological Tests</topic><topic>Pattern Recognition, Visual - physiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Recognition (Psychology) - physiology</topic><toplevel>online_resources</toplevel><creatorcontrib>FRANK, Gabriele</creatorcontrib><creatorcontrib>HENNIG-FAST, Kristina</creatorcontrib><creatorcontrib>KLÜNEMANN, Hans H</creatorcontrib><creatorcontrib>SCHMITZ, Gerd</creatorcontrib><creatorcontrib>GREENLEE, Mark W</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Alzheimer disease and associated disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FRANK, Gabriele</au><au>HENNIG-FAST, Kristina</au><au>KLÜNEMANN, Hans H</au><au>SCHMITZ, Gerd</au><au>GREENLEE, Mark W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential Impact of ApoE ε4 on Cortical Activation During Famous Face Recognition in Cognitively Intact Individuals and Patients With Amnestic Mild Cognitive Impairment</atitle><jtitle>Alzheimer disease and associated disorders</jtitle><addtitle>Alzheimer Dis Assoc Disord</addtitle><date>2011-07</date><risdate>2011</risdate><volume>25</volume><issue>3</issue><spage>250</spage><epage>261</epage><pages>250-261</pages><issn>0893-0341</issn><eissn>1546-4156</eissn><coden>ADADE2</coden><abstract>This study explores the neurofunctional correlates of the recognition of famous faces in patients with amnestic mild cognitive impairment (aMCI) and healthy controls depending on the genetic risk factor, Apolipoprotein E (ApoE) ε4. An event-related functional magnetic resonance imaging experiment was conducted while participants discriminated between famous and nonfamous faces. We compared the results of 32 healthy controls [17 ApoE ε4 carriers (E4+); 15 noncarriers (E4-)] with those of 30 patients with aMCI (16 E4+; 14 E4-). Despite comparable task performance, patients with aMCI, E4+ showed significantly less activation in a large cortical network including the left parahippocampal gyrus than patients with aMCI E4-. Furthermore, in the aMCI group, we found significantly reduced activation in the left parahippocampal gyrus and posterior cingulate cortex compared with the control group. Our results show that critical regions of the brain show functional decline associated with major risk factors, such as ApoE ε4 allele and neuropsychological signs of aMCI for the development of Alzheimer disease. Importantly, the ApoE genotype seems to influence cortical activation in patients with aMCI and to a lesser degree in healthy controls as well, who are without any cognitive symptoms.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>21192235</pmid><doi>10.1097/WAD.0b013e3182061636</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0893-0341
ispartof Alzheimer disease and associated disorders, 2011-07, Vol.25 (3), p.250-261
issn 0893-0341
1546-4156
language eng
recordid cdi_proquest_miscellaneous_885296584
source MEDLINE; Journals@Ovid Complete
subjects Amnesia - genetics
Apolipoprotein E4 - genetics
Biological and medical sciences
Cognitive Dysfunction - diagnosis
Cognitive Dysfunction - genetics
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Female
Genetic Predisposition to Disease - genetics
Genotype
Humans
Image Interpretation, Computer-Assisted
Magnetic Resonance Imaging
Male
Medical sciences
Memory Disorders - genetics
Middle Aged
Neurology
Neuropharmacology
Neuropsychological Tests
Pattern Recognition, Visual - physiology
Pharmacology. Drug treatments
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopharmacology
Recognition (Psychology) - physiology
title Differential Impact of ApoE ε4 on Cortical Activation During Famous Face Recognition in Cognitively Intact Individuals and Patients With Amnestic Mild Cognitive Impairment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T23%3A16%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20Impact%20of%20ApoE%20%CE%B54%20on%20Cortical%20Activation%20During%20Famous%20Face%20Recognition%20in%20Cognitively%20Intact%20Individuals%20and%20Patients%20With%20Amnestic%20Mild%20Cognitive%20Impairment&rft.jtitle=Alzheimer%20disease%20and%20associated%20disorders&rft.au=FRANK,%20Gabriele&rft.date=2011-07&rft.volume=25&rft.issue=3&rft.spage=250&rft.epage=261&rft.pages=250-261&rft.issn=0893-0341&rft.eissn=1546-4156&rft.coden=ADADE2&rft_id=info:doi/10.1097/WAD.0b013e3182061636&rft_dat=%3Cproquest_cross%3E885296584%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=885296584&rft_id=info:pmid/21192235&rfr_iscdi=true